The influenza vaccine safe for Cardiovascular patients- finds study.

As per the recent study results, Influenza vaccination is safe and efficacious for reducing cardiovascular morbidities and mortalities in patients with Myocardial Infarction. The study was published in the journal "Current Cardiology Reports." 

Influenza is a global health burden causing significant morbidity and mortality.  Death due to this is not just from respiratory causes but also other non-respiratory conditions. Influenza infection is a significant and well-established cause of the cardiovascular disease (CVD) and CV mortality. It is shown to reduce major adverse cardiovascular events (MACE) and CV mortality. There is a strong recommendation for its use in patients with established CVD or high risk for CVD as per the major society guidelines. Despite all this, the Influenza vaccine remains underutilized and is administered to stable outpatients majorly. There is no proper evidence on the safety and efficacy of influenza vaccination among patients with acute myocardial infarction (MI). 

Researchers reviewed previous literature and also conducted an updated meta-analysis of all the randomized control trials which included influenza vaccine and cardiovascular outcomes, including Influenza Vaccination after Myocardial Infarction (IAMI) and the recent Influenza Vaccine to Prevent Adverse Vascular Events (IVVE) trial. Pooled analysis of 8 RCTs had a total of 14,420 patients in this review.